FACTORS ASSOCIATED WITH GUT DYSBIOSIS IN INFANTS WITH BRONCHIOLITIS
Abstract
Abstract
The gut microbiome plays a key role in the development of the immune system and maintenance of mucosal homeostasis, while disruption of its balance, known as dysbiosis, is associated with increased susceptibility to infections.
The aim of this study was to investigate the association between viral etiology, prenatal and postnatal factors, and dysbiosis in infants with bronchiolitis.
This single-center, prospective, analytical study included 50 infants aged 1–12 months with clinically confirmed bronchiolitis. Nasopharyngeal swabs were analyzed using Multiplex Real-Time PCR to determine viral etiology, while fecal samples were analyzed using EnteroFLOR® Kiddy Real-Time PCR to assess the gut microbiome and classify eubiosis, mild dysbiosis, or severe dysbiosis. Statistical analysis included the chi-square test, Fisher’s exact test, and odds ratio, with a significance level of p<0.05.
Mild dysbiosis was detected in 58% of infants and severe dysbiosis in 26%. Respiratory syncytial virus was the most frequently detected virus, identified in 72% of infants. Dysbiosis was more frequent among infants who tested positive for respiratory syncytial virus (p<0.05). The use of systemic antibiotics before hospitalization, reported in 34% of infants, was associated with significantly increased odds of severe dysbiosis (odds ratio=18; p=0.00185).The presence of household pets was associated with mild dysbiosis (p=0.048), whereas the other demographic, prenatal, and postnatal factors were not significantly associated with dysbiosis.
Dysbiosis was common among infants with bronchiolitis, particularly among those with respiratory syncytial virus infection and previous exposure to systemic antibiotics, highlighting the importance of early identification of factors associated with gut microbiome disruption.
References
2. Tamburini S, Shen N, Wu HC, Clemente JC. The Microbiome in Early Life: Implications for Health Outcomes. Nat Med (2016) 22(7):713–22.
3. Renz H, Adkins BD, Bartfeld S, Blumberg RS, Farber DL, Garssen J, et al. The Neonatal Window of Opportunity-Early Priming for Life. J Allergy Clin Immunol (2018) 141(4):1212–4.
4. Shao Y, Forster SC, Tsaliki E, Vervier K, Strang A, Simpson N, et al. Stunted Microbiota and Opportunistic Pathogen Colonization in Caesarean-Section Birth. Nature (2019) 574(7776):117–21.
5. Rossi GA, Silvestri M, Colin AA. Viral Bronchiolitis in Children. N Engl J Med (2016) 374(18):1792–3.
6. Borchers AT, Chang C, Gershwin ME, Gershwin LJ. Respiratory Syncytial Virus–a Comprehensive Review. Clin Rev Allergy Immunol (2013) 45(3):331–79.
7. Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, et al. Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age. Pediatrics (2013) 132(2):e341–8.
8. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and Type 2 Cytokine Imbalance in Acute Respiratory Syncytial Virus Bronchiolitis. Am J Respir Crit Care Med (2003) 168(6):633–9.
9. Marsland BJ, Trompette A, Gollwitzer ES. The Gut-Lung Axis in Respiratory Disease. Ann Am Thorac Soc (2015) 12(Suppl 2):S150–6.
10. Dang AT, Marsland BJ. Microbes, Metabolites, and the Gut-Lung Axis. Mucosal Immunol (2019) 12(4):843–50.
11. Fernandez L, Langa S, Martin V, Maldonado A, Jimenez E, Martin R, et al. The Human Milk Microbiota: Origin and Potential Roles in Health and Disease. Pharmacol Res (2013) 69(1):1–10.
12. Mountzouris KC, Mccartney AL, Gibson GR. Intestinal Microflora of Human Infants and Current Trends for its Nutritional Modulation. Br J Nutr (2002) 87(5):405–20.
13. Russell SL, Gold MJ, Willing BP, Thorson L, Mcnagny KM, Finlay BB. Perinatal Antibiotic Treatment Affects Murine Microbiota, Immune Responses and Allergic Asthma. Gut Microbes (2013) 4(2):158–64.
14. Chai G, Governale L, Mcmahon AW, Trinidad JP, Staffa J, Murphy D. Trends of Outpatient Prescription Drug Utilization in US Children, 2002-2010. Pediatrics (2012) 130(1):23–31.
15. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data Set. Pediatrics (2006) 117(6):1979–87.
16. Warner BB, Deych E, Zhou Y, Hall-Moore C, Weinstock GM, Sodergren E, et al. Gut Bacteria Dysbiosis and Necrotising Enterocolitis in Very Low Birthweight Infants: A Prospective Case-Control Study. Lancet (2016) 387(10031):1928–36.
17. Fonseca W, Lukacs NW, Ptaschinski C. Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome. Front Immunol (2018) 9:226.
18. Garcia CG, Bhore R, Soriano-Fallas A, Trost M, Chason R, Ramilo O, et al. Risk Factors in Children Hospitalized With RSV Bronchiolitis Versus Non-RSV Bronchiolitis. Pediatrics (2010) 126(6):e1453–60.
19. Tahamtan A, Samadizadeh S, Rastegar M, Nakstad B, Salimi V. Respiratory Syncytial Virus Infection: Why Does Disease Severity Vary Among Individuals? Expert Rev Respir Med (2020) 14(4):415–23.
20. Tahamtan A, Askari FS, Bont L, Salimi V. Disease Severity in Respiratory Syncytial Virus Infection: Role of Host Genetic Variation. Rev Med Virol (2019) 29(2):e2026.
21. Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The Infant Microbiome Development: Mom Matters. Trends Mol Med (2015) 21(2):109–17.
22. De Steenhuijsen Piters W, Binkowska J, Bogaert D. Early Life Microbiota and Respiratory Tract Infections. Cell Host Microbe (2020) 28(2):223–32.
23. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early Infancy Microbial and Metabolic Alterations Affect Risk of Childhood Asthma. Sci Transl Med (2015) 7(307):307ra152.
24. Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson WO, Braun-Fahrlander C, et al. Exposure to Environmental Microorganisms and Childhood Asthma. N Engl J Med (2011) 364(8):701–9.
25. Karmaus W, Botezan C. Does a Higher Number of Siblings Protect Against the Development of Allergy and Asthma? A Review. J Epidemiol Community Health (2002) 56(3):209–17.
26. Fujimura KE, Demoor T, Rauch M, Faruqi AA, Jang S, Johnson CC, et al. House Dust Exposure Mediates Gut Microbiome Lactobacillus Enrichment and Airway Immune Defense Against Allergens and Virus Infection. Proc Natl Acad Sci USA (2014) 111(2):805–10.
27. Ownby DR, Johnson CC, Peterson EL. Exposure to Dogs and Cats in the First Year of Life and Risk of Allergic Sensitization at 6 to 7 Years of Age. JAMA (2002) 288(8):963–72.
28. Kristensen K, Henriksen L. Cesarean Section and Disease Associated With Immune Function. J Allergy Clin Immunol (2016) 137(2):587–90.
29. Wampach L, Heintz-Buschart A, Fritz JV, Ramiro-Garcia J, Habier J, Herold M, et al. Birth Mode is Associated With Earliest Strain-Conferred Gut Microbiome Functions and Immunostimulatory Potential. Nat Commun (2018) 9(1):5091.
30. Wampach L, Heintz-Buschart A, Hogan A, Muller EEL, Narayanasamy S, Laczny CC, et al. Colonization and Succession Within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes During the First Year of Life. Front Microbiol (2017) 8:738.
31. Rutayisire E, Huang K, Liu Y, Tao F. The Mode of Delivery Affects the Diversity and Colonization Pattern of the Gut Microbiota During the First Year of Infants' Life: A Systematic Review. BMC Gastroenterol (2016) 16(1):86.